One-Shot hope to protect bones during HIV therapy
NCT ID NCT06762730
Summary
This study tests if a single dose of zoledronic acid can prevent bone density loss that sometimes happens when people start HIV medication. Researchers will compare bone health over four years in 110 newly diagnosed adults who either receive the one-time infusion or just get regular check-ups. The goal is to see if this simple treatment can protect bones without needing ongoing medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hadassah Hebrew University Medical Center
RECRUITINGJerusalem, 9112001, Israel
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
-
Rambam Medical Center
NOT_YET_RECRUITINGHaifa, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sheba Medical Center
NOT_YET_RECRUITINGRamat Gan, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.